#GivingTuesday is almost over but it’s not too late to give a gift to the Melanoma Research Foundation (MRF) to help stop melanoma in its path. Christy and Dan share why ...
Today is #GivingTuesday! Read why Carola Supports the MRF. Melanoma is one of the fastest growing cancers in the world. Today, however, people across the globe stand...
#GivingTuesday is TOMORROW, December 1! Join Graham in Supporting the MRF. During the holiday season, we are especially grateful for the children in our lives and th...
#GivingTuesday is Tuesday, December 1, 2015! Join Julie and Amelia in Supporting the MRF. #GivingTuesday is Tuesday, December 1 and your gift to the Melanoma Researc...
Today, the FDA approved the targeted therapy combination of vemurafenib (Zelboraf®) with cobimetinib (Cotellic) for people who have advanced or metastatic melanoma and who...
Washington, D.C. – On Saturday, November 7th, the Washington, D.C. melanoma community will come together to honor those who have been impacted by melanoma and raise f...
Statement from Tim Turnham, Executive Director, Melanoma Research Foundation Washington, D.C.—Today the Food and Drug Administration (FDA) approved ipilimumab ...
For the last decade, Dr. Richard Carvajal has dedicated his career to the research and treatment of rare cancers like ocular melanoma (OM) and understands the need for more...
Statement from Tim Turnham, Executive Director, Melanoma Research Foundation The Melanoma Research Foundation (MRF) applauds the FDA’s approval of the c...
Organization Remains Only Melanoma-Dedicated Nonprofit in the U.S. To Receive Ranking WASHINGTON, D.C.— The Melanoma Research Foundation’s (MRF) s...
Leading Nonprofits in Melanoma Commend Committee’s Ongoing Support and Dedication to Advancing Breakthrough Melanoma Treatments WASHINGTON, D.C. —...
CURE TEAMS UP WITH MELANOMA RESEARCH FOUNDATION AND AIM AT MELANOMA TO COLLABORATE IN ADVOCACY SPOTLIGHT PARTNERSHIP PROGRAM PLAINSBORO, N.J. (June 4, 2015) — ...
Apr 17, 2026 ET - Apr 19, 2026
